Logotype for Marico Limited

Marico (MARICO) Q4 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Marico Limited

Q4 25/26 earnings summary

5 May, 2026

Executive summary

  • Achieved multi-year highs in consolidated revenue, with FY26 revenue up 26% YoY to ₹13,611 crore, India business up 28%, and international business up 20% YoY in INR terms, driven by robust execution, strategic diversification, and digital-first premium personal care growth.

  • Over 95% of the portfolio gained or sustained market share and penetration on a MAT basis.

  • Project Setu investments enhanced rural reach and execution, supporting general trade revival and sustained growth.

  • Several acquisitions completed, including full ownership of True Elements and majority stakes in Plix, 4700BC, and Cosmix, with positive synergy and profitability.

  • Audited standalone and consolidated financial results for FY26 were approved with an unmodified auditor's opinion.

Financial highlights

  • FY26 consolidated revenue: ₹13,611 crore (up 26% YoY); net profit: ₹1,813 crore; EBITDA: ₹2,474 crore; EPS: ₹13.62 (basic).

  • Foods portfolio exited the year at over ₹1,000 crore in revenue, premium personal care at ₹350+ crore ARR, and digital-first brands at ₹1,100+ crore ARR.

  • India business volume growth at 8% for FY26 and 9% for Q4FY26; international business constant currency growth at 20% for FY26.

  • Value-Added Hair Oils (VAHO) grew 20% for the year, with Q4 volume growth exceeding 20%.

  • Net cash generated from operating activities was ₹2,084 crore for FY26, up from ₹1,363 crore year-over-year.

Outlook and guidance

  • India business expected to sustain high single-digit volume growth in FY27; international business targets mid-teen constant currency growth.

  • Consolidated revenue expected to cross ₹15,000 crore and high-teen EBITDA growth in FY27, with a medium-term vision to surpass ₹20,000 crore revenue and mid-teen EBITDA CAGR by FY30.

  • Foods and premium personal care share in India business projected to rise to 27% in FY27 and one-third by FY30.

  • The Board recommended a final dividend of ₹4 per share for FY26, subject to approval.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more